Health and Fitness Health and Fitness
Thu, September 15, 2011
Wed, September 14, 2011
Tue, September 13, 2011
Mon, September 12, 2011
Sun, September 11, 2011
Sat, September 10, 2011
Fri, September 9, 2011
Thu, September 8, 2011
Wed, September 7, 2011
Tue, September 6, 2011
Mon, September 5, 2011
Sun, September 4, 2011
Sat, September 3, 2011
Fri, September 2, 2011
Thu, September 1, 2011
Wed, August 31, 2011
Tue, August 30, 2011
[ Tue, Aug 30th 2011 ] - Market Wire
00 a.m. ET
Mon, August 29, 2011
Fri, August 26, 2011
Thu, August 25, 2011
Wed, August 24, 2011
Tue, August 23, 2011
Mon, August 22, 2011
Sat, August 20, 2011
Fri, August 19, 2011
Thu, August 18, 2011
Wed, August 17, 2011
[ Wed, Aug 17th 2011 ] - Market Wire
PPD???????BioDuro?????
Tue, August 16, 2011
Mon, August 15, 2011
Fri, August 12, 2011
Thu, August 11, 2011

Salix Pharmaceuticals to Present at Three Investment Conferences in September


//health-fitness.news-articles.net/content/2011/ .. t-three-investment-conferences-in-september.html
Published in Health and Fitness on Wednesday, August 31st 2011 at 4:06 GMT by Market Wire   Print publication without navigation


RALEIGH, N.C.--([ BUSINESS WIRE ])--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three health care investment conferences during September 2011. Information of these conferences is provided below:

William Blair 2011 Life Sciences Conference
New York, NY Wednesday, Sept. 7 1:20 p.m. ET
Morgan Stanley Global Healthcare Unplugged Conference
New York, NY Tuesday, Sept. 13 3:55 p.m. ET
Jefferies 2011 Global Healthcare Conference
London, UK Tuesday, Sept. 27 9:20 a.m. ET

Interested parties can access a live audio web cast of these presentations at [ http://www.salix.com ]. A replay of the presentations will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salixa™s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Companya™s gastroenterology specialty sales and marketing team.

Salix trades on the NASDAQ Global Select Market under the ticker symbol aSLXPa.

For more information, please visit our Website at [ www.salix.com ] or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook ([ www.facebook.com/SalixPharma ]). Information on our web site is not incorporated in our SEC filings.


Publication Contributing Sources